Study Shows GLP1 Agonists Like Ozempic Can Lower Risk of Cirrhosis and Liver Cancer in Individuals with Type 2 Diabetes and Chronic Liver Disease
GLP1 Agonists Linked to Lower Risk of Cirrhosis and Liver Cancer: Study GLP1 Agonists Linked to Lower Risk of Cirrhosis and Liver Cancer: Study A nationwide study conducted in Sweden suggests that GLP1 agonists, such as Ozempic, could significantly reduce the risk of cirrhosis and liver cancer in individuals with type 2 diabetes and chronic … Read more